These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10221716)

  • 1. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel.
    Skinner JL; Riley SC; Gebbie AE; Glasier AF; Critchley HO
    Hum Reprod; 1999 Mar; 14(3):793-9. PubMed ID: 10221716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
    Pakarinen PI; Lähteenmäki P; Lehtonen E; Reima I
    Hum Reprod; 1998 Jul; 13(7):1846-53. PubMed ID: 9740437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
    Chegini N; Rhoton-Vlasak A; Williams RS
    Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception.
    Jones RL; Salamonsen LA; Critchley HO; Rogers PA; Affandi B; Findlay JK
    Mol Hum Reprod; 2000 Dec; 6(12):1107-17. PubMed ID: 11101694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
    Hampton AL; Nie G; Salamonsen LA
    Mol Hum Reprod; 1999 Apr; 5(4):365-71. PubMed ID: 10321809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
    Burton KA; Henderson TA; Hillier SG; Mason JI; Habib F; Brenner RM; Critchley HO
    Hum Reprod; 2003 Dec; 18(12):2610-7. PubMed ID: 14645180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
    Vincent AJ; Zhang J; Ostor A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
    Hum Reprod; 2000 Jan; 15(1):123-30. PubMed ID: 10611200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
    Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Bahamondes L; Hidalgo MM
    Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel.
    Hurskainen R; Salmi A; Paavonen J; Teperi J; Rutanen E
    Mol Hum Reprod; 2000 Nov; 6(11):1013-8. PubMed ID: 11044464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
    Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
    Rutanen EM; Salmi A; Nyman T
    Mol Hum Reprod; 1997 Sep; 3(9):749-54. PubMed ID: 9357999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women.
    Morison NB; Zhang J; Kaitu'u-Lino TJ; Fraser IS; Salamonsen LA
    Reproduction; 2007 Jan; 133(1):309-21. PubMed ID: 17244756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E; Vekemans M; Galant C; Rigot V; Lemoine P; Dubois D; Picquet C; Henriet P; Twagirayezu P; Sufi S; Eeckhout Y; Courtoy PJ
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.